Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
10,417 results
- T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents: Complete Statistical AnalysisIndependent statistical analysis of T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- T-cell Depleted Alternative Donor Transplantation: Complete Statistical AnalysisIndependent statistical analysis of T-cell Depleted Alternative Donor Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00968864).
- T-DM1Independent statistical analysis of T-DM1 and Palbociclib for Metastatic HER2 Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03530696).
- T-DM1 Alone Versus T-DM1 and Metronomic Temozolomide in Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases Following Stereotactic Radiosurgery: Complete Statistical AnalysisIndependent statistical analysis of T-DM1 Alone Versus T-DM1 and Metronomic Temozolomide in Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases Following Stereotactic Radiosurgery: primary endpoint results, effect estimate with confidence interval, sample-size…
- T-jet®Independent statistical analysis of Comparison of a Needle-free Injection Method With a Needle-syringe Injection Method: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- T1GERIndependent statistical analysis of A Study of SIMPONI® to Arrest Beta-cell Loss in Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- T2007-002 Clofarabine, Etoposide, Cyclophosphamide in Relapsed Acute Myelogenous Leukemia (AML): Complete Statistical AnalysisIndependent statistical analysis of T2007-002 Clofarabine, Etoposide, Cyclophosphamide in Relapsed Acute Myelogenous Leukemia (AML): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00939653).
- T2D_MTUIndependent statistical analysis of Impact of Muscle and Tendon Dysfunction in People With Type 2 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- t2pIndependent statistical analysis of txt2protect: Using Text Messaging to Increase HPV Vaccination Among Young Sexual Minority Men: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- T3PAHIndependent statistical analysis of Tamoxifen Therapy to Treat Pulmonary Arterial Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03528902).
- TACACIndependent statistical analysis of Taxotere and Adriamycin/Cytoxan (AC) Validation in Breast Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00206518).
- Taclonex Ointment With Hydrogel Patch Occlusion for the Treatment of Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of Taclonex Ointment With Hydrogel Patch Occlusion for the Treatment of Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Tacrolimus and Mycophenolate Mofetil (MMF) in GVHD Prophylactic Regimen Compared to Tacrolimus and Methotrexate (MTX: Complete Statistical AnalysisIndependent statistical analysis of Tacrolimus and Mycophenolate Mofetil (MMF) in GVHD Prophylactic Regimen Compared to Tacrolimus and Methotrexate (MTX: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer: primary endpoint results,…
- TACTIC AFIndependent statistical analysis of Safety Study on Stopping Anticoagulation Medication in Patients With a History of Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- TactiSenseIndependent statistical analysis of TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03354663).
- TAILOR-PCIIndependent statistical analysis of Tailored Antiplatelet Therapy Following PCI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01742117).
- Tailored Approaches to Improve Medication Adherence: Complete Statistical AnalysisIndependent statistical analysis of Tailored Approaches to Improve Medication Adherence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01643473).
- Tailored-AFIndependent statistical analysis of Tailored vs. Anatomical Ablation Strategy for Persistent Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04702451).
- Tailoring Shared Decision Making for Lung Cancer Screening in Persons Living With HIV: Complete Statistical AnalysisIndependent statistical analysis of Tailoring Shared Decision Making for Lung Cancer Screening in Persons Living With HIV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Tailoring Treatment Targets for Early Autism Intervention in Africa: Complete Statistical AnalysisIndependent statistical analysis of Tailoring Treatment Targets for Early Autism Intervention in Africa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04068688).
- TAK-114 Single- and Multiple-Dose Phase 1 Study: Complete Statistical AnalysisIndependent statistical analysis of TAK-114 Single- and Multiple-Dose Phase 1 Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02286518).
- TALAPRO-2Independent statistical analysis of Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03395197).
- Talazoparib For Neoadjuvant Treatment Of Germline BRCA1/2 Mutation Patients With Early Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Talazoparib For Neoadjuvant Treatment Of Germline BRCA1/2 Mutation Patients With Early Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer: primary endpoint results, effect estimate with confidence interval,…
- TALCIndependent statistical analysis of Asthma Clinical Research Network (ACRN) Trial - Tiotropium Bromide as an Alternative to Increased Inhaled Corticosteroid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid (TALC):…
- Tamibarotene Plus Venetoclax/Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML): Complete Statistical AnalysisIndependent statistical analysis of Tamibarotene Plus Venetoclax/Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…
- TANDEMIndependent statistical analysis of Study of Safety, Tolerability, and Efficacy of a Combination Treatment of LJN452 and CVC in Adult Patients With NASH and Liver Fibrosis: primary endpoint results, effect estimate with…
- Tandem Auto Transplantation in Myeloma Patients With <12 Months of Prior Treatment: Complete Statistical AnalysisIndependent statistical analysis of Tandem Auto Transplantation in Myeloma Patients With
- Tandem VR: Synchronized Nature-Based Experiences in Virtual Reality for Hospice Patients and Their Caregivers: Complete Statistical AnalysisIndependent statistical analysis of Tandem VR: Synchronized Nature-Based Experiences in Virtual Reality for Hospice Patients and Their Caregivers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- TANGOIndependent statistical analysis of A Phase 3 Study of Tanezumab for Chronic Low Back Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- TANGOIndependent statistical analysis of CER-001 Therapy as a Novel Approach to Treat Genetic Orphan Diseases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- TAPIndependent statistical analysis of Postoperative Pain Control for Prostatectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00913068).
- TAPIndependent statistical analysis of Transversus Abdominis Plane (TAP) Block Using Liposomal Bupivacaine in Metabolic and Bariatric Surgery Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- TAPIndependent statistical analysis of Trial Comparing Transversus Abdominis Plane Block Versus Epidural Anesthesia for Pain Management in Colorectal Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- TAP HYSIndependent statistical analysis of Transversus Abdominis Plane (TAP) Block Laparoscopic Hysterectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01074229).
- TAP-PIndependent statistical analysis of Can a Novel Telemedicine Tool Reduce Disparities Related to the Identification of Preschool Children With Autism?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- TAPASIndependent statistical analysis of TissuePAtchDS--P ™ PArotidectomy Trial.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04116762).
- TAPERIndependent statistical analysis of Randomized, Double-Blind, Placebo-Controlled Pilot Study on the Safety and Effectiveness of LUCEMYRA During an Opioid Taper in Treatment of Withdrawal: primary endpoint results, effect estimate with confidence interval,…
- TAPPASIndependent statistical analysis of Perioperative Administration of Tranexamic Acid for Placenta Previa and Accreta Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- TARCEVA (Erlotinib) in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC): Complete Statistical AnalysisIndependent statistical analysis of TARCEVA (Erlotinib) in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- TARDOXIndependent statistical analysis of Targeted Chemotherapy Using Focused Ultrasound for Liver Tumours: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02181075).
- TARGETIndependent statistical analysis of Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- TARGETIndependent statistical analysis of Role of On-site CT-derived FFR in the Management of Suspect CAD Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Targeted T Cells After Neoadjuvant Chemotherapy in Treating Women With Stage II or III Breast Cancer Undergoing Surgery: Complete Statistical AnalysisIndependent statistical analysis of Targeted T Cells After Neoadjuvant Chemotherapy in Treating Women With Stage II or III Breast Cancer Undergoing Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Targeting Cellular Senescence With Senolytics to Improve Skeletal Health in Older Humans: Complete Statistical AnalysisIndependent statistical analysis of Targeting Cellular Senescence With Senolytics to Improve Skeletal Health in Older Humans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Targeting IL-17A for Treatment-Resistant Depression: Complete Statistical AnalysisIndependent statistical analysis of Targeting IL-17A for Treatment-Resistant Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04979910).
- Targeting Reconsolidation to Prevent Return of Fear: Complete Statistical AnalysisIndependent statistical analysis of Targeting Reconsolidation to Prevent Return of Fear: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01623830).